Search results for “Hidradenitis suppurativa” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 246 patents, we discovered top 39 key players by total patent application. Novartis AG, Incyte Corp., Janssen Biotech are dominant in this area. They take 37.40% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 38
Incyte Corp.
Delaware, United States
Patent: 29
Janssen Biotech
Belgium
Patent: 25
AbbVie Biotechnology Ltd.
Bermuda
Patent: 16
Eli Lilly & Co.
Indiana, United States
Patent: 14
Henlez ApS
Denmark
Patent: 11
McNeil Pharmaceutical
United States
Patent: 11
Pfizer Inc.
New York, United States
Patent: 10
STARTUP
Azora Therapeutics, Inc.
California, United States
Patent: 8
XBiotech, Inc.
Texas, United States
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 15 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Azora Therapeutics, Inc.
California, United States
Patent: 8
STARTUP
Inflazome Ltd.
DUBLIN, Ireland
Patent: 4
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 196 patents applied in the last 5 years. We discover 33 most active companies in this area. The fast-growing Novartis AG, Incyte Corp., Janssen Biotech take 46.94% of patent filing during this period.
Novartis AG
Basel-Stadt, Switzerland
Patent: 38
Incyte Corp.
Delaware, United States
Patent: 29
Janssen Biotech
Belgium
Patent: 25
Eli Lilly & Co.
Indiana, United States
Patent: 14
Henlez ApS
Denmark
Patent: 11
Pfizer Inc.
New York, United States
Patent: 10
STARTUP
Azora Therapeutics, Inc.
California, United States
Patent: 8
Sol-Gel Technologies Ltd.
Israel
Patent: 6
CSL Innovation Pty Ltd.
Australia
Patent: 6
ChemoCentryx, Inc.
California, United States
Patent: 6
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 196 patents in last 5 years, we discover 33 new entrants. Novartis AG, Incyte Corp., Janssen Biotech are the most active new entrants in this area.
Novartis AG
Basel-Stadt, Switzerland
Patent: 38
Incyte Corp.
Delaware, United States
Patent: 29
Janssen Biotech
Belgium
Patent: 25
Eli Lilly & Co.
Indiana, United States
Patent: 14
Henlez ApS
Denmark
Patent: 11
Pfizer Inc.
New York, United States
Patent: 10
STARTUP
Azora Therapeutics, Inc.
California, United States
Patent: 8
Sol-Gel Technologies Ltd.
Israel
Patent: 6
CSL Innovation Pty Ltd.
Australia
Patent: 6
ChemoCentryx, Inc.
California, United States
Patent: 6
Research Institutions
Order by:
Innovation Intensity
With the analysis among 14 patents, we discovered top 8 universities and scientific research institutions by total patent application. Universidad de Alcalá, Universidad de Murcia, Universite Paris Est Creteil Val De Marne are dominant in this area. They take 57.14% of the total patent filing.
Universidad de Alcalá
Spain
Patent: 3
Universidad de Murcia
Murcia, Spain
Patent: 2
Universite Paris Est Creteil Val De Marne
France
Patent: 2
Thomas Jefferson University
Pennsylvania, United States
Patent: 1
The Rockefeller University
New York, United States
Patent: 1
University of Delaware
Delaware, United States
Patent: 1
The George Washington University Medical Center
District of Columbia, United States
Patent: 1
Université de Limoges
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: